Wegovy: Genetic profile may predict best response to weight-

Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk's weight-loss drug Wegovy

Related Keywords

Washington , United States , Mayo Clinic In Rochester , Minnesota , Andres Acosta , Novo Nordisk , Digestive Disease Week , Mayo Clinic ,